Distinguished in Anomalous Left Coronary Artery from the Pulmonary Artery

Wen Y. Zhang

Zhejiang Key Laboratory Of Research And Translation For Kidney Deficiency Stasis Turbidity Disease, 
Hangzhou, CN 
Distinguished in Anomalous Left Coronary Artery from the Pulmonary Artery
Zhejiang Key Laboratory Of Research And Translation For Kidney Deficiency Stasis Turbidity Disease, 
Hangzhou, CN 
OverviewLocationsClinical Research

Overview

Wen Zhang practices in Hangzhou, China. Zhang is rated as a Distinguished expert by MediFind in the treatment of Anomalous Left Coronary Artery from the Pulmonary Artery. Their top areas of expertise are Anomalous Left Coronary Artery from the Pulmonary Artery, Diabetic Nephropathy, Wilson Disease, Type 2 Diabetes (T2D), and Angioplasty.

Their clinical research consists of co-authoring 103 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Anomalous Left Coronary Artery from the Pulmonary Artery.

Locations

Zhejiang Key Laboratory Of Research And Translation For Kidney Deficiency Stasis Turbidity Disease, Hangzhou, China
Other Locations
Beijing Key Laboratory For Bioengineering And Sensing Technology, Beijing, 100083, China
Tianjin Key Laboratory Of Aquatic Science And Technology, Tianjin, China
Shanghai, 200241, China
Suzhou, 215131, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

103 Total Publications

Traceable nanoparticles with mitochondria-targeting pyruvate-Cu induce cuproptosis for enhanced triple-negative breast cancer therapy in a mouse model.
Traceable nanoparticles with mitochondria-targeting pyruvate-Cu induce cuproptosis for enhanced triple-negative breast cancer therapy in a mouse model.
Journal: Materials horizons
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhang's expertise for a condition
ConditionClose
    View All 35 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile